# Synvisc to Treat Osteoarthritis of the Temporomandibular Joint

> **NCT00078351** · PHASE2 · COMPLETED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 60 (—)

## Conditions studied

- Osteoarthritis

## Interventions

- **PROCEDURE:** High molecular weight hylan (Synvisc) injection

## Key facts

- **NCT ID:** NCT00078351
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00078351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00078351, "Synvisc to Treat Osteoarthritis of the Temporomandibular Joint". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00078351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*